Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: No. Zajicek J Mult Scler. 2014 Aug; 20(9):1165-6. PMID: 27352433. Abstract CommentRecommendBookmarkWatch
